Research Study

Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Principal Investigator 
Kevin Song

Overview

Body Locations and Systems 
Blood
Disorders and Conditions 
ClinicalTrials.gov# 
NCT01324947
Status 
Closed to Recruitment
Study Start/End 
Aug 1, 2011 to Aug 31, 2013
Locations 
Vancouver General Hospital
Name/Title 
Lisa Basque, Research Nurse
Phone 
604-875-4111 ext.69014
Email Address 
lbasque@bccancer.bc.ca
Purpose of Study 

The purpose of this study is to evaluate the efficacy and safety of pomalidomide monotherapy in subjects with refractory or relapsed and refractory multiple myeloma who were enrolled in study CC-4047-MM-003 (NCT01311687) and discontinued treatment with high-dose dexamethasone due to disease progression.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.